Divis Labs up 21% as USFDA to lift import alert on Vizag unit

Shares of Divi's Laboratories

today zoomed over 21 per cent after it said the US health

regulator will lift an import alert imposed on the company's

Unit-II in Visakhapatnam.

The stock soared 21.37 per cent to Rs 1,117 on BSE.

At NSE, shares of the company jumped 20.99 per cent to Rs

1,117.60.

In terms of equity volume, 10 lakh shares of the company

were traded on BSE and over 85 lakh shares changed hands at

NSE during the morning trade.

Divi's Laboratories today said the US health regulator

will lift an import alert imposed on the company's Unit-II in

Visakhapatnam and is moving to close out the warning letter

issued to the unit.

The company "has been informed by the United States Food

and Drug Administration (USFDA) that it will be lifting the

Import Alert 66-40 and move to close out the warning letter

issued to the company's Unit-II at Visakhapatnam", Divi's

Laboratories said in a filing to BSE.

It, however, did not share any details and timelines for

resolution of the matter.

Earlier in July, the company announced that USFDA had

moved to lift Import Alert 99-32 imposed on the unit.

 

(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)